After that, it is possible to examine whether changes in nSMase2 content predict the impact of glutathione depletion-mediated ROS levels on tumor cell growth or apoptosis [55] and determine whether glutathione depletion is a viable strategy for HCC management. Here, SMPD3 is linked to hepatocellular carcinoma.